My clinical and research interests include a focus on precision oncology in the management of patients with lung cancers. I am particularly interested in novel biomarker development, management of patients with oncogene driven cancer (such as ALK, ROS1, EGFR, MET, etc.) and understanding mechanisms of acquired resistance.
I believe that there is no one-size fits all approach in medicine, especially in cancer therapy. I strive to use the best scientific principles available and tailor these to the individual needs and circumstances of each patient.
I am interested in targeted therapies and novel biomarkers. My true passion outside of medicine is classical piano performance. I also dabble with sketch comedy, film, and skiing on the side.
I have given multiple lectures on advances in precision oncology, targeted therapies and acquired resistance.